Herraez E - Search Results

1

Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma.

Herraez E, Romero MR, Macias RIR, Monte MJ, Marin JJG. Herraez E, et al. Hepatobiliary Surg Nutr. 2020 Apr;9(2):211-214. doi: 10.21037/hbsn.2019.10.11. Hepatobiliary Surg Nutr. 2020. PMID: 32355682 Free PMC article. No abstract available.

2

Importance and limitations of chemotherapy among the available treatments for gastrointestinal tumours.

Marin JJ, Romero MR, Blazquez AG, Herraez E, Keck E, Briz O. Marin JJ, et al. Among authors: herraez e. Anticancer Agents Med Chem. 2009 Feb;9(2):162-84. doi: 10.2174/187152009787313828. Anticancer Agents Med Chem. 2009. PMID: 19199863 Review.

3

Protective effect of bile acid derivatives in phalloidin-induced rat liver toxicity.

Herraez E, Macias RI, Vazquez-Tato J, Hierro C, Monte MJ, Marin JJ. Herraez E, et al. Toxicol Appl Pharmacol. 2009 Aug 15;239(1):21-8. doi: 10.1016/j.taap.2009.04.017. Epub 2009 May 4. Toxicol Appl Pharmacol. 2009. PMID: 19409403

4

In vitro inhibition of OATP-mediated uptake of phalloidin using bile acid derivatives.

Herraez E, Macias RI, Vazquez-Tato J, Vicens M, Monte MJ, Marin JJ. Herraez E, et al. Toxicol Appl Pharmacol. 2009 Aug 15;239(1):13-20. doi: 10.1016/j.taap.2009.04.024. Epub 2009 May 21. Toxicol Appl Pharmacol. 2009. PMID: 19464309

5

Overview of the molecular bases of resistance to chemotherapy in liver and gastrointestinal tumours.

Marin JJ, Romero MR, Martinez-Becerra P, Herraez E, Briz O. Marin JJ, et al. Among authors: herraez e. Curr Mol Med. 2009 Dec;9(9):1108-29. doi: 10.2174/156652409789839125. Curr Mol Med. 2009. PMID: 19747110 Review.

6

Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins.

Herraez E, Gonzalez-Sanchez E, Vaquero J, Romero MR, Serrano MA, Marin JJ, Briz O. Herraez E, et al. Mol Pharm. 2012 Sep 4;9(9):2565-76. doi: 10.1021/mp300178a. Epub 2012 Aug 1. Mol Pharm. 2012. PMID: 22800197

7

Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib.

Herraez E, Lozano E, Macias RI, Vaquero J, Bujanda L, Banales JM, Marin JJ, Briz O. Herraez E, et al. Hepatology. 2013 Sep;58(3):1065-73. doi: 10.1002/hep.26425. Epub 2013 Jul 30. Hepatology. 2013. PMID: 23532667

8

Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds.

Vaquero J, Briz O, Herraez E, Muntané J, Marin JJ. Vaquero J, et al. Among authors: herraez e. Biochim Biophys Acta. 2013 Oct;1833(10):2212-9. doi: 10.1016/j.bbamcr.2013.05.006. Epub 2013 May 13. Biochim Biophys Acta. 2013. PMID: 23680185 Free article.

9

Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology.

Lozano E, Herraez E, Briz O, Robledo VS, Hernandez-Iglesias J, Gonzalez-Hernandez A, Marin JJ. Lozano E, et al. Among authors: herraez e. Biomed Res Int. 2013;2013:692071. doi: 10.1155/2013/692071. Epub 2013 Jul 31. Biomed Res Int. 2013. PMID: 23984399 Free PMC article. Review.

10

Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development.

Lozano E, Sanchez-Vicente L, Monte MJ, Herraez E, Briz O, Banales JM, Marin JJ, Macias RI. Lozano E, et al. Among authors: herraez e. Mol Cancer Res. 2014 Jan;12(1):91-100. doi: 10.1158/1541-7786.MCR-13-0503. Epub 2013 Nov 19. Mol Cancer Res. 2014. PMID: 24255171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters